RxDoctor Payments Data

Renee Clary

Allergy · Bellaire, TXNPI 1841474459

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 233 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,840, 2.0 times the $917 reported in 2021. That places this record below the midpoint for allergy clinicians in TX, where the typical reported total is $5,140.

$5,190in general payments, 2019–2025

Across 233 payments — averaging $22.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$696
  • GSK$617
  • Ferring Pharmaceuticals Inc.$490
  • AstraZeneca$483
  • Takeda Pharmaceuticals U.S.A., Inc.$304
  • CSL Behring$303
  • plus $2K from 22 others

What the payments were for

  • Consulting fees$180%
  • Food & beverage$5,02097%
  • Education$1533%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,190 in reported general payments places this provider in the 50th percentile of 69 allergy providers in Texas.

See all allergy providers in Texas

Other allergy in Bellaire

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →